These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25450)

  • 1. [Importance of pharmacotherapy in the rehabilitation of schizophrenic patients].
    Wojdysławska I
    Psychiatr Pol; 1977; 11(6):683-8. PubMed ID: 25450
    [No Abstract]   [Full Text] [Related]  

  • 2. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia.
    Dursun S
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):3-4. PubMed ID: 16144780
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is depot formulation a long-term optimal treatment option?].
    Musch A
    Med Monatsschr Pharm; 2005 Nov; 28(11):414-6. PubMed ID: 16309031
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prophylactic efficacy of long-acting vs. short-acting neuroleptics in schizophrenic out-patients (author's transl)].
    Tegeler J; Lehmann E; Stockschlaeder M
    Nervenarzt; 1980 Nov; 51(11):654-61. PubMed ID: 6109262
    [No Abstract]   [Full Text] [Related]  

  • 5. New advances in pharmacotherapy for early psychosis.
    Emsley R
    Early Interv Psychiatry; 2009 Sep; 3 Suppl 1():S8-12. PubMed ID: 21352195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Longterm therapy of schizophrenia].
    Pajonk FG; Wobrock T; Falkai P
    Fortschr Neurol Psychiatr; 2005 Mar; 73(3):161-74; quiz 175-7. PubMed ID: 15747226
    [No Abstract]   [Full Text] [Related]  

  • 7. Raising the bar for treatment expectations in schizophrenia: achieving remission as a routine goal of antipsychotic pharmacotherapy.
    Nasrallah HA; Dursun SM
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):3-5. PubMed ID: 17046983
    [No Abstract]   [Full Text] [Related]  

  • 8. Schizophrenia.
    Kane JM
    N Engl J Med; 1996 Jan; 334(1):34-41. PubMed ID: 7494570
    [No Abstract]   [Full Text] [Related]  

  • 9. Depot antipsychotics in practice. Their rôle in schizophrenia and related psychoses.
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():1-78. PubMed ID: 2881965
    [No Abstract]   [Full Text] [Related]  

  • 10. Antipsychotic medication in the treatment of schizophrenia.
    Kane JM
    Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term therapy with depot neuroleptics. Prevention of recurrence in chronic schizophrenic patients].
    Bergener M; Husser J; Kranzhoff EU; Charap A
    Fortschr Med; 1986 Oct; 104(40):756-60. PubMed ID: 2877927
    [No Abstract]   [Full Text] [Related]  

  • 12. Compliance and the rehabilitation alliance.
    Aquila R; Weiden PJ; Emanuel M
    J Clin Psychiatry; 1999; 60 Suppl 19():23-7; discussion 28-9. PubMed ID: 10507277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longterm maintenance therapy with depot haloperidol in schizophrenia.
    Zbytovský J
    Homeost Health Dis; 1991; 33(5-6):287. PubMed ID: 18265499
    [No Abstract]   [Full Text] [Related]  

  • 14. [5 years' experience with prolonged-action neuroleptics].
    Lopez-Ibor Aliño JM; Tabares Pujante J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(5):721-31. PubMed ID: 4150175
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological standards in schizophrenia treatment].
    Jarema M; Kiejna A; Landowski J; Meder J; Jolanta RJ; Rybakowski J
    Psychiatr Pol; 2006; 40(6):1171-205. PubMed ID: 17444297
    [No Abstract]   [Full Text] [Related]  

  • 16. [Psychological aspects of depot treatment of schizophrenic syndromes].
    Jacobsson L; Odling H
    Lakartidningen; 1980 Oct; 77(40):3522-6. PubMed ID: 6109045
    [No Abstract]   [Full Text] [Related]  

  • 17. [To increase compliance-knowledge. Only every second schizophrenia patient remains faithful to the therapy].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():108. PubMed ID: 14579500
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of long-acting risperidone.
    Parker G
    Psychiatr Serv; 2005 Jan; 56(1):105-6; author reply 106-7. PubMed ID: 15637203
    [No Abstract]   [Full Text] [Related]  

  • 19. Review of treatments that can ameliorate nonadherence in patients with schizophrenia.
    Kane JM
    J Clin Psychiatry; 2006; 67 Suppl 5():9-14. PubMed ID: 16822091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost analysis of the strategies in the treatment of schizophrenics: the place of sustained release injectable atypical antipsychotics].
    Gasquet I; Bouhassira M; Launois R
    Encephale; 2005; 31(4 Pt 1):517-8. PubMed ID: 16389719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.